Drug profile · INN
resmetirom
REZDIFFRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
resmetirom (REZDIFFRA) is an FDA-listed pharmaceutical active ingredient. Associated with Madrigal Pharmaceuticals EU Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN resmetirom
Brand REZDIFFRA
Route ORAL
Formulation TABLET
ATC code A05
Originator Madrigal Pharmaceuticals EU Limited
Frequently asked questions
What is resmetirom?
resmetirom (REZDIFFRA) is an FDA-listed pharmaceutical active ingredient. Associated with Madrigal Pharmaceuticals EU Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for resmetirom?
REZDIFFRA is a marketed brand name for resmetirom. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of resmetirom?
resmetirom has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.